Size: px
Start display at page:

Download ""

Transcription

1

2

3

4

5

6

7

8

9

10

11

12

13

14 2) Andrews and Domonkos: Hauseweives' eczma, Disease of the Skin 5 th Ed., Saunders, Philadelphia and London, 69, ) Pillsbury et al.: Dermtitis and Eczema of the Hands, Contact dermatitis, Dermatology, Saunders, Phil adelphia and London, 209, ) R. L. Suttonjr.: Chronic dermatitis of the Hands and Feet, Diseases of the Skin 11th. Ed., Mosby, St. Louis, , ) R. L. Sutton jr. and S. Ayres jr.: Dermatitis of the Hands, Etiology and Principles of Treatment, with Observations Concerning a Hyperkeratotic Dermatitis of the Volar Skin, A. M. A. Arch. Dermal. & Syph., 68:

Atlas_j060419

Atlas_j060419 Hill s Atlas of Veterinary Clinical Anatomy 1 29 30 2 3 4 5 31 32 33 34 35 36 37 6 7 8 9 10 11 12 13 38 39 40 41 14 15 16 17 18 19 20 21 22 23 24 25 26 27 42 43 44 45 46 47 48 49 50 51 52 53 54 55 28 81

More information

取扱説明書

取扱説明書 ED-601 ED-501 ED-401 2 3 4 23 14 5 6 18 10 7 1 2 6 3 4 8 9 16 16 16 12 1 2 18 10 2 1 5 12 11 1 2 1 2 12 1 2 13 16 14 3 2 4 1 1 2 16 3 4 18 15 1 2 16 2 3 1 1 2 3 18 17 18 22 19 D A C 20 A B 22 B C D 22

More information

野岩鉄道の旅

野岩鉄道の旅 29th 5:13 5:34 5:56 6:00 6:12 6:20 6:21 6:25 6:29 6:31 6:34 6:38 6:40 6:45 6:52 6:56 7:01 7:07 7:11 7:32 7:34 7:50 7:58 8:03 8:17 8:36 8:44 5:50 5:54 6:15 6:38 6:39 6:51 6:59 6:59 7:03 7:08 7:08 7:11 7:15

More information

EPSON

EPSON B K L & & & & & & & & L & & & & & & & K & & & & & L L L & & & K L L L & & L L L & & & & & & & & & & & & & & & & & & & & & & & & & & & L & K L K & & & & & & & L L & & L & & L L & & & & &

More information

™…

™… 2/10 15 2010. No1362 1 1 216315 91430 Q A & 0.23% 1 1.4% 04-7120-2020 050-5540-2023 Q A & 1 1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 1 2 3 4 5 6 7 8 9 10

More information

2012_10_A_cover.indd

2012_10_A_cover.indd c %& r Z \ W n % & & % % & % & & % % % & % & % & & % & % %& % & % & % % % & & & W W W W A

More information

2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1

2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 2.8% 2.0% 2.4% 2.4% 0.4% 0.1% 0.3% 0.5% 3.8% 5.6% 25.6% 29.3% 64.6% 60.0% 1 16 24 21 20 20 23 10 11 9 10 3 3 3 2 3 1 3 4 6 8 2 0 1 2 3 4 5 6 0 1 2 3 4 5 6 0 1 2 3 4 5 6 3 4 Q & A Q1 A1 Q2 A2 Q3 A3 7

More information

Q&A最低資本金特例030131.PDF

Q&A最低資本金特例030131.PDF & 1 2 2 3 2 2 3 2 2 3 10 11 10 90 12 13 14 15 16 17 18 19 20 2 2 3 21 2 2 3 22 23 24 25 20 10 26 27 28 10 8 1 29 30 10 8 2 31 32 2 2 3 33 10 8 3 10 11 2 34 10 8 3 10 12 2 35 36 20 10 37 38 39 40 41 42

More information

bumon_pro.indd

bumon_pro.indd q w e r t y u i o!0 !1!2!3 !4!5!6 !7!8!9 @0 @1 @2 @3 @4 @5 @6 @7 @8 @9 #0 #1 #2 #3 #4 #5 #6 #7 #8 #0 $0 $1 $2 $3 $4 $5 $6 $7 $8 $9 %0 %1 %2 %3 %4 %5 %6 %7 %8 %9 ^0 ^1 ^2 ^3 ^4 ^5 ^6 ^7 ^8 ^9 &0 &1 &2

More information

‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q

‡o‡P†C‡P‡Q”R„û†^‡P†C‡P‡Q ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,, Q & A ,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,

More information

2012_05_GLK_cover.indd

2012_05_GLK_cover.indd c %& r Z \ W W n q & F % % & & % & & % % % & % & % & % & % & % & F F % % % & & & & % & A

More information

13 21 13 3 10 2010 5 6 20 32 10 10 3 JR 14 3 1 8 2 15 6 ( ) 135 1 8 2 15 135 5 135 1 8 2 15 5 JR 135 1 8 2 15 JR 1 135 1 8 2 15 JR 135 135 135 JR 135 1 8 2 15 135 1 8

More information

untitled

untitled 2015 2004 6 22 (1) 2 3 4 50 550 2 80 10 3 100 10 165 50 1,000 2223 2 6,800 8,400 5001,000 23 () 5 1 1 02 04 5,400 3 46 80 90 70 7090 610 02 18.2 05 22.6 1120 3,000 30 5 90 15 90 22.8 1015 80 90 1120

More information

広報えちぜん12月号_4校.indd

広報えちぜん12月号_4校.indd 24 7,140,000 24 3,129,000 24 20,685,000 24 9,292,500 24 8,925,000 24 13,492,500 24 NO. 5,670,000 24 4,470,900 24 8,494,500 24 2,341,500 24 4,021,500 Jr. [ ] 128 1214 845 855 1345 1355 2015 2025 121 127

More information

2 3 4 5 6 7 8 ( ) 9 10 11 12 13 14 S JR 16 22 23 24 25 27 29 30 31 32 33 34 35 36 37 38 39 40 41 JR JR 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72

More information

report_c.ai

report_c.ai 39 182646163205 40 41 42 43 44 45 46 47 48 49 ( 50 1 2 1 P.4 2 P.5 51 50 20 52 3 4 3 P.4 4 P.5 53 JR 10 54 5 6 5 P.4 6 P.5 55 20 20 510 26 46 56 26 57 ( 510 58 26 59 ( 40 = 510 60 26 26 61 ( ( ( ) 10 62

More information

がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性

がん患者の終末期ケアにおける通所リハビリテーションの役割 介護保険によるがん終末期ケアの可能性 2 3 3 6 7 49 53 13 61 22 27 65 68 34 47 71 73 4 5 7 6 8 9 10 11 12 13 14 15 44 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

More information

1 2441 2711 7 126 3 1 20 244127 11 18 9 B 10,000 10,000 1 1 40 60,000 28,000 98,000 1 20 100,000 22,000 132,000 7 2 1,014,000 7 2 924,000 1 2 317

1 2441 2711 7 126 3 1 20 244127 11 18 9 B 10,000 10,000 1 1 40 60,000 28,000 98,000 1 20 100,000 22,000 132,000 7 2 1,014,000 7 2 924,000 1 2 317 1 2441 2711 7 126 3 1 20 244127 11 18 9 B 10,000 10,000 1 1 40 60,000 28,000 98,000 1 20 100,000 22,000 132,000 7 2 1,014,000 7 2 924,000 1 2 317 40 60 2 3 4 4 7 9 12 2 3 3 4 1 414 26 1. 2. 3. 4. 5. 6.

More information

第122号.indd

第122号.indd -1- -2- -3- 0852-36-5150 0852-36-5163-4- -5- -6- -7- 1st 1-1 1-2 1-3 1-4 1-5 -8- 2nd M2 E2 D2 J2 C2-9- 3rd M3 E3 D3 J3 C3-10- 4th M4 E4 D4 J4 C4-11- -12- M5 E5 J5 D5 C5 5th -13- -14- NEWS NEWS -15- NEWS

More information

Current Therapy of Skin Laser Surgery Takeshi SHIMBASHI * (Received July 15, 1996) It has been remarkably progressed in cutaneous laser surgery. Anderson elucidated the theory of selected photothermolysis

More information

.K.C.h...C...ren

.K.C.h...C...ren 1 1, 2 4.1 3.0 5.2 3.7 2.8 4.6 3.9 3.2 4.6 0.3 0.0 0.7 0.2 0.0 0.5 0.3 0.1 0.5 3.7 2.7 4.8 3.5 2.6 4.4 3.6 2.9 4.3 0.3 0.0 0.7 0.9 0.5 1.3 0.6 0.4 0.9 0.6 0.2 1.0 0.4 0.1 0.7 0.5 0.2 0.7 5.0 3.9 6.2 5.0

More information

1. Albright, F., Burnett, C. H., Smith, P. H. and Parson, W.: Pseudohypoparathyroidism an example of "Seabnght-Bantam syndrome", Endocrino- logy, 30:922-932, 1942. 2. Elrick, H., Albright, F., Bartter,

More information

untitled

untitled 1 2 3 http://www.info.pmda.go.jp/ 4 5 6 7 8 9 10 11 (Quincke s edema) 12 13 梗 疼 () 14 15 J Allergy Clin Immunol 115;S483-S523, 2005 16 17 IgE IgE IgE 18 19 20 21 腿 22 Hydrocortisone 100 200 mg 5 mg/kg

More information

医科的 に診 た外歯瘻 図1 症 例1:右 鼻翼 基 部の瘻 孔 図2 凝 血が付着 して いる 症 例1:初 耳 展 図3 症 例1:抜 歯 後4 50: 1 日 治癒 してい る 右上 犬歯 歯 肉 の発赤 腫 脹 が 見 ら れ る 図4 症 例2:初 図5 頬 部皮 膚の 浸潤 性 発 赤腫 脹 が 見 症 例2:蜂 窩 織 炎 の 所 見 を示 図6 症 例2:初 診 か ら10日 後 に瘻

More information

2009 Aida et al. Caries Res 2006;40 2000 100 % 78.7 88.0 96.6 98.8 98.8 98.8 100.0 100.0 100 75 69.4 50 75.3 74.8 73.3 73.1 73.0 72.4 71.8 71.7 51.7 40.2 69.4 68.8 73.6 25 22.3 32.8 21.9 22.9 22.1

More information

æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of

æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of æ æ2 \ R esults of Open Patch Tests in Control Solutions Containing Ammonium Thioglycollate or Cysteine Group Using Cold Permanent Wave 3 \ Results of Patch Tests Using Cold Permanent Wave Solutions on

More information

() 2

() 2 1 () 2 2 4 3 6,500 4 5 2 6 A B A B A B A B - A B 7 8 A B A B A B 9 JR JR 10 11 6 5 12 17 6 13 14 B A A B A B A B 2 1 8 15 8 16 17 9 18 3 4 5 mm mm 19 2 20 3 6 7 11 12 13 14 18 4 3 2 1 21 3 12 13 14 16

More information

Core Ethics Vol. : - NICU : : - A B C D

Core Ethics Vol. : - NICU : : - A B C D Core Ethics Vol.,NMR...... Core Ethics Vol. : - NICU : : - A B C D b: Duff and Campbell A B C: D : a B C b Core Ethics Vol. : -, : C D :.. D.. bd D CD AB CD : Duff C b C B : Core Ethics Vol. C D B A D

More information

- 2 -

- 2 - - 2 - - 3 - - 4 - UJI - 5 - 50 22 3.5 3 50-6 - 60.5 45 10 2004 4 23 500 228-7 - 3 8-8 - - 9 - http://ranking.goo.ne.jp/ranking/011/antenna_shop/ - 10 - 14 4 17 10 90 17 48 66 ) ) - 11 - A () ) 291 2030

More information

PX-047A Series

PX-047A Series B K L & L & A B C D E F A B A B C A B C A B A B A B C D E F G P BB H I y y & & K L L & & K L L L L & & & & L d L & & & & L L & & & L & & & & L & & & & & & & & L L L L L L & & & A B C D E F G

More information

- 1 - - 2 - 320 421 928 1115 12 8 116 124 2 7 4 5 428 515 530 624 921 1115 1-3 - 100 250-4 - - 5 - - 6 - - 7 - - 8 - - 9 - & & - 11 - - 12 - GT GT - 13 - GT - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - -

More information

産衛誌57-4たより.indb

産衛誌57-4たより.indb A89 26 7 1 9 4 33 1 87 A90 24 A91 23 ACOH2014 A92 4 1 2 3 4 5 6 7 A93 A94 A95 A96 A97 A98 A99 A100 A101 27 8 1 9 A102 4 33 A103 A104 26 3 140 27 1 A105 27 A106 A107 A108 A109 A110 A111 A112 A113 et al

More information

6 6 6 6 1 2 3 4 5 6 7 8 R B1 B1 1 2 3 4 5 6 7 8 9

6 6 6 6 1 2 3 4 5 6 7 8 R B1 B1 1 2 3 4 5 6 7 8 9 6 6 6 6 1 2 3 4 5 6 7 8 R B1 B1 1 2 3 4 5 6 7 8 9 B1F 7306730 96730 1F & 1069 2F & & 93069 3F 4F 1069 969 5F 6F 7F & & 8F 8F 9F 8306515 96.0534582130 1068 1066 4.0534582180 83069 0120-53-4305 0534542218

More information

1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18

1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18 1 1 (1) 1 1 1 (2) 1 (3) 3 3 4 4 2 6 (1) 6 (2) 6 6 6 7 3 7 (1) 7 7 9 10 10 11 (2) 12 12 14 16 (3) 17 17 18 (4) 18 18 18 ( ) 20 10 26 39 1 2 ( ) 3 338 4 5 6 22 10 7 50 60 8 600 400 600 400 9 10 454 11 45

More information

% 4.4% % 5.0% % 4.5% % 2.7% % 2.0% % 3.6% 5.1% 4.5% 2.6% 3.6%

% 4.4% % 5.0% % 4.5% % 2.7% % 2.0% % 3.6% 5.1% 4.5% 2.6% 3.6% 11 10 12 8.9% 4.4% 2005 9.2% 5.0% 2006 6.5% 4.5% 2007 1.0% 2.7% 2008 1.9% 2.0% 2009 7.3% 3.6% 5.1% 4.5% 2.6% 3.6% 2012 2011 2010 2004 H22.3.27 2011 3 10 2010 9 10 2 128 60 191041 100 100 2011 JR km 89

More information

はじめにお読みください

はじめにお読みください START 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 @ 33 34 35 36 37 38 39 40 41 & @ 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 & 60 61 62 63 64 65 66 67 68

More information

2012 10 7,150 8 22 3,159 2,457 78656 21 30 87 330 289 940 456 1450 681 22 60 803 2570 536 1780 251 8 1 2,475 78%2 374 12% 1 342 2 312 3 215 1 1,025 2 753 3 90 1 1,937 612 612 203 136 4 1 2 1,085

More information

株式会社ウェッズ

株式会社ウェッズ 39th 1 2 39th 25,000 500 300 20,000 15,000 400 300 200 10,000 5,000 200 100 100 0 0 0 16,000 50 5 12,000 8,000 4,000 40 30 20 10 4 3 2 1 0 0 0 3 4 39th 5 6 39th 7 N E W P R O D U C T S 8 39th 9 10 CO.,LTD.

More information

奈良県立医科大学耳鼻咽喉・頭頸部外科学-2016年Facebookページ記事.pages

奈良県立医科大学耳鼻咽喉・頭頸部外科学-2016年Facebookページ記事.pages 2016 1 10 ( ) 1:22 UTC+09 52 2016 1 10 ( ) 1:30 UTC+09 70 2016 1 10 ( ) 10:15 UTC+09 2016 1 10 ( ) 13:29 UTC+09 70 Lucky Cat 2016 1 15 ( ) 18:54 UTC+09 2 ( 5 ) 5 ( 6 ) 7 2016 1 29 ( ) 17:55 UTC+09 2 (

More information

TK747取扱説明書

TK747取扱説明書 D D D D D D D E D D D D D D D D ; ; ; ; ; ; ; ; ; ; ; ; ; D D D D D D D D C C C C C ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; ;;;;; C C C C C C C C C C C C C C C C C D D D

More information

Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11

Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 Vol.170 2004.9.9 9 17 9 17 1000 8 10 9 17 14:00 17:00 30 28 Vol.171 2004.9.15 14 100 5 10 15 52 53 55 1 7 55 58 63 3 26 53 3 6 9 2 3 6 9 6 52 53 55 3 9 5 1 7 10 14 4 12 8 11 9.17 10 15 38 51 53 55 6 2

More information

2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th ed

2005 8) Robbins and Cotran Pathologic Basis of Disease (7th ed.) Kumar V, Abbas AK, Fausto N (eds.), W.B. Saunders, ) Rubin s Pathology (4 th ed 23344 mfukayama-tky@umin.ac.jp http://pathol.umin.ac.jp/ 19 50 2 / 19 50 3 / http://pathol/umin.ac.jp 1) Basic Pathology (7 th edition): Kumar V, Cotran RS, Robbins SL (eds.), W.B. Saunders, 2002 2) Essential

More information

76

76 ! # % & % & %& %& " $ 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 % & &! & $ & " & $ & # & ' 91 92 $ % $'%! %(% " %(% # &)% & 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 !$!$ "% "%

More information

†ı25”Y„o-PDF.ren

†ı25”Y„o-PDF.ren 12,000 10,000 8,000 6,000 4,000 2,000 0 1998 1999 2000 2001 2002 2003 2004 1,200 1,000 800 600 400 200 0 1998 1999 2000 2001 2002 2003 2004 $ "! ''" '' ''$ ''% ''& '''! " ' & % $ "! ''" ' '$ '% '& ''!

More information

労働法総論講義(2・完)

労働法総論講義(2・完) 173 174 175 176 .... 177 ............ NHK NHK.. NHK.................. 178 ........ 179 180 181 182 183 .. 184 185 186 187 .............. 188 .. 189 .. 190 .. 191 192 193 .. 194 195 196 .............. 197

More information

10 10 10095 95 100 108

10 10 10095 95 100 108 25491231 21 21 114 10 10 10095 95 100 108 10 10 2510 079685 10 100 109 20 2015 110 134 e [ 350 350 145 18 111 112 16 18 16 18 1816 18 20 48 25 20315 28 113 114 25 05 03 01 20 100150 Q & A Q A 18 16 Q &

More information

b n m, m m, b n 3

b n m, m m, b n 3 13th Annual Worlds of Flavor International Conference & Festival z x c v z x c v 2 b n m, m m, b n 3 . 0 1 2 3 4 5. 0 1 2 3 4 4 5 6 7 8 6 7 8 5 9 0 1 2 3 9 0 1 2 3 6 4 5 6 7 8 4 5 6 7 8 9 7 0 1 2 3 9 0

More information

2 4 診断推論講座 各論 腹痛 1 腹痛の主な原因 表 1 症例 70 2 numeric rating scale NRS mmHg X 2 重篤な血管性疾患 表

2 4 診断推論講座 各論 腹痛 1 腹痛の主な原因 表 1 症例 70 2 numeric rating scale NRS mmHg X 2 重篤な血管性疾患 表 2 4 診断推論講座 各論 腹痛 1 腹痛の主な原因 表 1 症例 70 2 numeric rating scale NRS 4 10 50 160 90mmHg691836.3 X 2 重篤な血管性疾患 表 2 72 73 表 1 腹痛をきたす疾患の緊急度と治療担当診療科による分類 1 2 3 4 5 表 2 3 血管性疾患と炎症性疾患の症状 腹膜刺激症状 表 1 表 3 74 75 表 3 腹膜刺激症状を修飾する因子

More information